OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 39 th Annual J.P. Morgan Healthcare Conference being held virtually on January 11-14, 2021. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 13 th at 3:40 p.m. Eastern time. The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website and accessibl
MIAMI, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Opko Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 39th Annual J.P. Morgan Healthcare Conference being held virtually on January 11-14, 2021. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 13th at 3:40 p.m. Eastern time.
The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website and accessible by clicking here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com